Chronic diseases are among the leading causes of death, disability, and poor quality of life in the United States today . Chronic conditions can be debilitating and difficult to manage, and it is not surprising that many of those with a deep-seated prolonged illness have a greater risk of developing a life-threatening condition. But Integrative Cancer Centers of America is here to help. Integrative Cancer Centers of America offers patients fully personalized, targeted treatment plans in conjunction with customized medications to accurately diagnose and provide potential treatments options to help manage difficult chronic diseases.
For two decades, ICCA has been combining the latest conventional treatment methods with the most effective research-based integrative medicine options to provide our patients with the highest quality of care possible. With cutting-edge technologies and therapies, ICCA's staff is well skilled in diagnosing and treating a range of infectious, autoimmune, and chronic diseases, including:
Our mission at ICCA is to provide answers and solutions for those struggling with chronic infection and disease. Often, patients suffer needlessly with painful and debilitating symptoms as a result of misdiagnoses or insufficient and otherwise inadequate treatment methods. ICCA's clinical experience, advanced technology, and precision diagnostics give us a decided edge when properly diagnosing and treating potential underlying causes for chronic diseases. We understand that living with a chronic disease and autoimmune condition can be extremely frustrating and debilitating. Many patients spend years, even decades, searching for doctors who will acknowledge their affliction and provide actionable solutions. Some patients may be faced with doubt and rejection of their undiagnosed conditions and others may be placed in an endless cycle of pain killers and symptom management. With 20 years of experience dealing with complex and resistance chronic infections, ICCA is uniquely equipped to provide answers and solutions other clinics may not be able to.
ICCA has found that many patients arrive after struggling to receive effective and comprehensive treatment from their previous providers. Very often, those patients have been misdiagnosed with a wide variety of potential chronic illnesses. ICCA's precision testing and genetics-based diagnostics has found that many chronic diseases are the result of chronic infections like Lyme disease.
Lyme disease is a condition we consistently treat at our clinic because of its difficulty to identify and the lackluster approach to treatment by conventional medicine. Lyme disease can mimic the symptoms of over three-hundred different conditions and, if it is not caught soon after infection, Lyme can become resistant to treatment. Few physicians and treatment facilities are equipped to effectively address Lyme's varied and complex etiologies.
Integrative Cancer Centers of America is dedicated to continual research and development and we have remained at the forefront of treatment with leading edge diagnostics and genetically customized medicines specifically designed for patients suffering from chronic disease. As a result, we often help patients who have been misdiagnosed find real and actionable targets for their condition. In years of researching and treating chronic infections ICCA has been able to help thousands of patients and our experience has led to amazing breakthroughs in how we approach chronic illness.
ICCA has researched and published significant breakthroughs on the connection between infections and the development of cancer. Many patients we treat are unaware of cancers they may have developed due to chronic infections they are struggling with. Inversely, we also treat many cancer patients who are unaware of underlying infections that are contributing to their cancer. Our research has found significant correlations between viruses, bacteria, parasites, and fungus in the development of specific cancers. ICCA specializes in treating cancer and chronic disease giving us a unique vantage point for treating patients who suffer from both. We are distinctly positioned to provide a comprehensive treatment protocol that can help chronic infection patients address or even potentially avoid the development of cancer.
The body is a complex web of interactions that can make every patient unique in their disease. Viruses can introduce DNA into individual cells, altering the cellular signaling with viral proteins and promoting possible mutation and cancer growth . Bacterial infections also can contribute to the development of cancer. Typically, through mechanisms associated with inflammation, bacteria can increase mutations and affect epigenetic genes involved in the body's natural cancer defense and cell mutation . At ICCA we understand these connections better than anyone and provide a personalized response to account for the unique circumstances of each case.
Treating cancer and infection as unrelated can severely stunt progress, making treatment a long and arduous process with no clear end in sight. If a patient has one of these chronic infections, they may be at a higher risk of developing a correlating cancer. Additionally, if they are fighting against one of these cancers and the doctor has not addressed the possibility of infection, they may be missing a large contributing factor to the condition. Integrative Cancer Centers of America has nearly two decades of clinical experience researching and treating infections that may potentially lead to a variety of cancers, including:
Epstein Barr Virus (EBV)
- Hodgkin Lymphoma
- Burkitt Lymphoma, Diffuse Large B Cell Lymphoma, Pyrothorax Lymphoma, Nasopharyngeal Carcinoma, Gastric Carcinoma, and Leiomyosarcoma
Hepatitis B & C Virus (HBV & HCV)
- Hepatocellular carcinoma.
Human Herpes Virus 6 (HHV-6)
- Oral Squamous Cell Carcinoma, Hodgkin's Disease, non-Hodgkin's lymphoma, and cervical carcinoma
Human Herpes Virus 8 (HHV-8)
- Karposi's Sarcoma and Primary Effusion Lymphoma
Human Papillomavirus (HPV)
- Cervical Cancer.
Human T-Cell Leukemia Virus Type 1 (HTLV-1)
- Adult T-Cell Leukemia/Lymphoma
Merkel Cell Polyomavirus (MCPyV)
- Merkel Cell Carcinomas
Epstein Borrelia burgdorferi
- Primary Cutaneous, B-Cell Lymphoma
- Lung Cancer
- Gastric Carcinoma
- Gastric and Colon Carcinoma
Salmonella typhi 1
- Colorectal Cancer
- Bladder carcinoma
- Asperigillus flavus and Asperigillus parasiticus-hepatocellular carcinoma
We are here to help patients take control of their health. Our treatments are not limited to standard methods such as antibiotics, but also include research-based natural therapies from all around the world. We incorporate an integrative approach that provides treatment from multiple angles and modalities. By addressing the many factors of infection and disease, we hope to provide more treatment options for our patients. Providing the type of care and compassion they deserve.
If you are suffering from a known or unknown chronic illness don't hesitate to contact the ICCA team at 866-456-4379. We have trained specialists standing by to help answer your questions and set you on the path to healing.
 CDC. About Chronic Diseases. National Center for Chronic Disease Prevention and Health Promotion 2019 10/23/19 [cited 2020 1/6]; Available from: https://www.cdc.gov/
 Griffiths, P.D. and R.J. Whitley, Chapter 7 - Cytomegalovirus, in Practical Guidelines in Antiviral Therapy, C.A.B. Boucher, et al., Editors. 2002, Elsevier: Amsterdam. p. 151-171
 Nicolson, G.L., R. Gan, and J. Haier, Multiple co-infections (Mycoplasma, Chlamydia, human herpes virus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms. APMIS, 2003. 111(5): p. 557-566.
 Steere, A.C., J. Coburn, and L. Glickstein, The emergence of Lyme disease. The Journal of Clinical Investigation, 2004. 113(8): p. 1093-1101.
 Afari, N. and D.J.A.J.o.P. Buchwald, Chronic fatigue syndrome: a review. 2003. 160(2): p. 221-236.
 Adler, G.K. and R.J.R.D.C. Geenen, Hypothalamic–pituitary–adrenal and autonomic nervous system functioning in fibromyalgia. 2005. 31(1): p. 187-202.
 Cohen, J.I.J.N.E.J.o.M., Epstein–Barr virus infection. 2000. 343(7): p. 481-492.
 Fernández-Menéndez, S., et al., Epstein–Barr virus and multiple sclerosis. From evidence to therapeutic strategies. Journal of the Neurological Sciences, 2016. 361: p. 213-219.
 Arsuaga, M., et al., Misdiagnosis of Babesiosis as Malaria, Equatorial Guinea, 2014. 2018. 24(8): p. 1588.
 Smith, A.J., J. Oertle, and D. Prato, Cancer and Infectious Causes. Open Journal of Medical Microbiology, 2014. Vol.04No.03: p. 17.